NIH-funded research R01 grant

Engineered metabolite nanoparticles to modulate macrophages in obesity

Official title: Engineered metabolite-based nanoparticles for immunomodulation of macrophages to treat obesity

Funded at University of Cincinnati · NIH-11440598 · Data updated 2026-11-12

Aims to use specially designed nanoparticles to rebalance inflammation in fat tissue and improve health in people with obesity.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startSeptember 1, 2025
Project endMay 31, 2029
Funding year2025
Award (this year)$2,889,213
NIH project number7R01DK144500-02
Project IDNIH-11440598 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity who could benefit from improved metabolic health and reduced inflammation.

Less likely to help

Individuals without obesity or those whose obesity is not primarily driven by inflammatory processes may see limited benefit.

What this research studies

This study develops a nanoparticle-based immunotherapy aimed at shifting fat tissue macrophages from a pro-inflammatory state to an anti-inflammatory one, with the goal of reducing chronic inflammation and improving metabolic health in obesity. Researchers will design and test metabolite-based nanoparticles that interact with immune cells in adipose tissue to promote a healthier immune balance. The project spans preclinical work and potential translational steps to move toward human studies if results are promising.

Why it matters

Potential benefit: If successful, this approach could lessen inflammation and improve metabolic outcomes in obesity, potentially reducing related diseases.

How similar studies have gone: Preclinical nanoparticle immunotherapies have shown promise in modulating macrophage behavior in metabolic tissues, supporting further exploration.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Hassani Najafabadi, Alireza — University of Cincinnati
  • Study coordinator: Hassani Najafabadi, Alireza

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.